DUBLIN, Nov. 8, 2022 /PRNewswire/ -- Alkermes plc
(Nasdaq: ALKS) announced today that management will participate in
a fireside chat at the Stifel 2022 Healthcare Conference on
Tuesday, Nov. 15, 2022 at
8:00 a.m. ET (1:00 p.m. GMT). The live webcast may be accessed
under the Investors tab on www.alkermes.com and will be
archived for 14 days.
About Alkermes plc
Alkermes plc is a fully-integrated, global
biopharmaceutical company developing innovative medicines in the
fields of neuroscience and oncology. The company has a portfolio of
proprietary commercial products focused on alcohol dependence,
opioid dependence, schizophrenia and bipolar I disorder, and a
pipeline of product candidates in development for
neurological disorders and cancer. Headquartered
in Dublin, Ireland, Alkermes has a research and
development center in Waltham, Massachusetts; a research
and manufacturing facility in Athlone, Ireland; and a
manufacturing facility in Wilmington, Ohio. For more
information, please visit Alkermes' website
at www.alkermes.com.
Contact:
Sandy Coombs
Investor Relations
+1 781 609 6377
Logo -
https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/alkermes-to-participate-in-the-stifel-healthcare-conference-301672168.html